14 research outputs found
Allergy diagnosis in children IgE-sensitized to peanut : clinical and immunological evaluation
Background: Peanut allergy is often life-long and affects quality of life since accidental
ingestion may lead to severe or even fatal reactions. Sensitization to peanut can
be due to genuine peanut allergy or to cross-sensitization due to birch pollen.
Peanut allergy diagnosis is usually based on clinical history, skin prick test (SPT)
and presence of IgE-antibodies (IgE-ab) to peanut but these tests often need to be
confirmed with an oral food challenge which may cause severe allergic
reactions. Measurements of IgE-ab to specific proteins in an allergen source
(component resolved diagnostics [CRD]) and basophil allergen threshold
sensitivity (CD-sens) may be valuable tools for diagnosis of peanut allergy.
Important allergen proteins in peanut are the storage proteins: Ara h 1, Ara h 2
and Ara h 3 and the PR-10 protein [birch-homologue] Ara h 8.
Aim: The aim of this thesis was to evaluate different diagnostic methods in children
IgE-sensitized to peanut with a suspected peanut allergy.
Method: Paper I investigated if it is possible to predict the outcome of double-blind
placebo-controlled food challenge (DBPCFC) with peanut by measuring CDsens to peanut and Ara h 2 as well as IgE-ab to peanut components (Ara h 1, Ara
h 2, Ara h 3, Ara h 8 or Ara h 9) (n=38). In Paper II, the reproducibility of
DBFCFC and CD-sens were investigated. Twenty-seven children underwent
DBPCFC followed by a single-blinded food challenge with peanut, and CD-sens
was measured before the two first peanut challenges. Paper III reports a birch
pollen allergic child with cross-sensitization to peanut who had a severe reaction
after eating a large amount of peanuts. The fourth paper investigated the
outcome of a peanut challenge in relation to IgG4-ab (n=58). Paper V studied 20
birch pollen allergic children cross-sensitized to peanut in relation to CD-sens to
peanut and Ara h 8.
Results: In Paper I, 25 children had a positive DBPCFC and 92% of the children were
positive in CD-sens. The remaining two children were low responders and could
not be evaluated. Children with positive DBPCFC reactions had significantly
higher levels of IgE-ab to peanut, Ara h 1, Ara h 2 and Ara h 3 than children
with negative reactions. All children negative in CD-sens to peanut and Ara h 2
were also negative in challenge. In paper II, 14/27 children were positive at both
active challenges but not placebo. Only three of these children reacted
consistently at the same dose with the same severity score. All children with a
positive or a negative CD-sens at the first challenge were also CD-sens
positive/negative at the second challenge. Paper III revealed that the girl with
birch pollen allergy who reacted with anaphylaxis after peanut ingestion was
mono-sensitized to Ara h 8. Paper IV showed that children positive at peanut
challenge had significantly higher levels of IgG4-ab to peanut and Ara h 2 than
children negative at the challenge. The peanut and Ara h 2 IgG4/IgE-ab ratios
were significantly higher in children who tolerated peanut than in allergic
children. In Paper V, all children passed peanut challenge without any objective
symptoms, but five experienced subjective symptoms from the oral cavity. CDsens to peanut was negative in 19/20 children but 17/20 were positive in CDsens to Ara h 8.
Conclusion: CD-sens is a promising diagnostic method with good reproducibility in the
diagnosis of peanut allergy and may exclude a peanut allergy. IgE-ab to the
peanut storage proteins (Ara h 1, Ara h 2 and Ara h 3) seem to confirm a genuine
peanut allergy. A peanut challenge can discriminate between positive and
negative reactions but does not predict the severity of an allergic reaction. Birchpollen allergic children IgE-sensitized to peanut and Ara h 8 but not to Ara h 1,
Ara h 2 and Ara h 3 have basophils sensitized with IgE-ab to Ara h 8 which can
be activated by Ara h 8 proteins and initiate allergic inflammation. Children IgEsensitization to peanut who nonetheless tolerate peanuts are characterized by low
levels of IgG4-antibodies to peanut and Ara h 2 but relatively high IgG4/IgE
antibody ratios
Basophil allergen threshold sensitivity, and peanut allergen components in relation to DBPCFC in children with suspected peanut allergy
Oral peanut challenge identifies an allergy but the peanut allergen threshold sensitivity is not reproducible.
BACKGROUND: Double-blind placebo-controlled food challenge, DBPCFC, the gold standard for diagnosing food allergy, is time-consuming and potentially dangerous. A basophil allergen threshold sensitivity test, CD-sens, has shown promising results as a diagnostic tool in food allergy. OBJECTIVES: To evaluate the reproducibility of oral peanut challenge and compare the outcome to CD-sens in peanut-sensitized children. METHODS: Twenty-seven children (4-19 years) underwent a DBPCFC followed by a single-blind oral food-challenge. The peanut challenges (1 mg to 5 g) were evaluated by severity scoring. Blood samples were drawn for CD-sens before the two first challenges. RESULTS: Thirteen children (48%) did not react at any of the challenges. Fourteen reacted at both peanut challenges but not to placebo. Only two of these children reacted at the same threshold dose and with the same severity score. All other children scored differently or reacted at different doses. For children with a positive challenge the geometric mean of the ratio of the doses was 1.834 (p = 0.307) and the arithmetic mean of the difference between the severity scores was 0.143 (p = 0.952). No association was obtained between the two peanut challenges regarding severity score (r(s) = 0.11, p = 0.71) or threshold dose (r(s) = 0.35, p = 0.22). Among the children positive in peanut challenge, 12 were positive in CD-sens. Two were low-responders and could not be evaluated. Geometric mean of the ratio of CD-sens values in children with a positive challenge was 1.035 (p = 0.505) but unlike for the severity score and the threshold dose the association between the two CD-sens values was strong (r(s) = 0.94, P<0.001). CONCLUSIONS: For a positive/negative test the reproducibility is 100% for both peanut challenge and CD-sens. However, a comparison of the degree of allergen threshold sensitivity between the two tests is not possible since the threshold dose and severity scoring is not reproducible
Is Molecular Allergology Cost-Effective and Cost Saving in Children with Suspected Peanut Allergy Compared to Double Blind Placebo Controlled Food Challenge (DBPCFC) and Skin Prick Test in US, Europe and Asia?
Severity scores according to Astier [<b>20</b>] in the same child at the two peanut challenges.
<p>Severity scores according to Astier <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0053465#pone.0053465-Astier1" target="_blank">[<b>20</b>]</a> in the same child at the two peanut challenges.</p
Peanut CD-sens values in the same child at the two peanut challenges.
<p>Peanut CD-sens values in the same child at the two peanut challenges.</p
The differences in severity score (challenge 2–challenge 1) in each child with positive peanut challenges, presented as a Bland-Altman plot.
<p>The arithmetic mean of the difference between the severity scores was 0.143.</p
Threshold doses of peanut in the same child at the two peanut challenges.
<p>The amount peanut eaten were divided into 5 dose steps: Dose 1 = 0.001 g; Dose 2 = 0.01 g; Dose 3 = 0.1 g; Dose 4 = 1 g; Dose 5 = 3.6–5 g.</p
Symptom score according to Astier [20] to evaluate clinical reactions in DBPCFC.
<p>Symptom score according to Astier <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0053465#pone.0053465-Astier1" target="_blank">[20]</a> to evaluate clinical reactions in DBPCFC.</p
The differences in the ratio for peanut CD-sens values (challenge 2/challenge 1) in each child with positive peanut challenges, presented as a Bland-Altman plot with logarithmically transformed data.
<p>Geometric mean of the ratio of CD-sens values was 1.035.</p